Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension

QR Code

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension

Makoto AiharaDepartment of Ophthalmology, University of Tokyo School of Medicine, Tokyo, JapanAbstract: An elevated intraocular pressure (IOP) is one of the most important risk factors for the development of glaucoma, which causes progressive optic neuropathy. Lowering IOP is currently the only ther...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Makoto Aihara
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/e7b4aeeffb7a4d58be435fa98e06a802
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
par: Dorota Pozarowska
Publié: (2010)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
par: Liu Y, et autres
Publié: (2012)

Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
par: Gerrett Brief, et autres
Publié: (2010)

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
par: Henny JM Beckers, et autres
Publié: (2009)

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
par: Janulevičienė I, et autres
Publié: (2012)

Blood pressure, ocular perfusion pressure and open-angle glaucoma in patients with systemic hypertension
par: Cantor E, et autres
Publié: (2018)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
par: Lanzl I, et autres
Publié: (2013)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
par: Ikeda Y, et autres
Publié: (2016)

The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma
par: Nakamoto K, et autres
Publié: (2018)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
par: Ermiş&nbsp;SS
Publié: (2012)

Effect of Fasting on Intraocular Pressure (IOP) in Normal Individuals
par: A Soleymani,, et autres
Publié: (2009)

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
par: Pillunat LE, et autres
Publié: (2017)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
par: Nakano T, et autres
Publié: (2016)

Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma
par: Chandra P, et autres
Publié: (2011)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
par: Ruangvaravate N, et autres
Publié: (2020)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
par: Wang N, et autres
Publié: (2020)

Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
par: Tamçelik N, et autres
Publié: (2017)

A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
par: Stevens A, et autres
Publié: (2016)

Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension
par: Fang Y, et autres
Publié: (2017)

Effects of different sleeping positions on intraocular pressure in secondary open-angle glaucoma and glaucoma suspect patients
par: Sedgewick JH, et autres
Publié: (2018)

Pattern of intraocular pressure reduction following laser trabeculoplasty in open-angle glaucoma patients: comparison between selective and nonselective treatment
par: Almeida Jr ED, et autres
Publié: (2011)

The effect of daily life activities on intraocular pressure related variations in open-angle glaucoma
par: Kevin Gillmann, et autres
Publié: (2021)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
par: Shiratori N, et autres
Publié: (2021)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
par: Andrea Russo, et autres
Publié: (2009)

Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
par: Naito T, et autres
Publié: (2015)

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
par: Makoto Ishikawa, et autres
Publié: (2009)

Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients
par: Mohammed K El Mallah, et autres
Publié: (2010)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
par: Miguel A Teus, et autres
Publié: (2009)

Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
par: Syed MF, et autres
Publié: (2011)

Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension
par: Sophia K Mirza, et autres
Publié: (2010)

Correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, and normal eyes
par: Figueiredo BP, et autres
Publié: (2013)

Effect of Preoperative Intraocular Pressure in Patients with and without Intolerance to Their IOP-Lowering Medication on the Outcome of Trabectome Surgery
par: Wons J, et autres
Publié: (2021)

Publisher Correction: MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension
par: María I. Canut, et autres
Publié: (2021)

Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension
par: Michele Iester
Publié: (2008)

Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
par: Pillunat LE, et autres
Publié: (2016)

Effect of systemic antihypertensives on change in intraocular pressure after initiating topical prostaglandins for primary open-angle glaucoma
par: Siddiqui M, et autres
Publié: (2019)

Structural Changes in the Optic Disc and Macula Detected by Swept-Source Optical Coherence Tomography After Surgical Intraocular Pressure Reduction in Patients with Open-Angle Glaucoma
par: Vessani R, et autres
Publié: (2021)

Retinal Blood Flow Velocity Change in Parafoveal Capillary after Topical Tafluprost Treatment in Eyes with Primary Open-angle Glaucoma
par: Yuto Iida, et autres
Publié: (2017)

Plasma GDF-15 concentration is not elevated in open-angle glaucoma.
par: Wouter H G Hubens, et autres
Publié: (2021)

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
par: Laube T, et autres
Publié: (2012)